TASHA PRESTON: Open Payments
NPI 1811205925 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 70 payments from 11 companies in 2025. Trend: 2023 $1,176 · 2024 $709 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $458 |
| Janssen Pharmaceuticals, Inc | 12 | $338 |
| ABBVIE INC. | 13 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $211 |
| Supernus Pharmaceuticals, Inc. | 7 | $141 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| Lundbeck LLC | 3 | $61 |
| Corcept Therapeutics | 1 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: REXULTI, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, ABILIFY ASIMTUFII, Qelbree, SPRAVATO, Auvelity.
Industry payments across OK — which companies pay providers there.
